The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Editors' (re)View
Editors' (re)View
Editor’s (re)View: Not a good week for India’s Sun Pharma and API manufacturer Hikal
Sun’s factory is under Import Alert until it becomes compliant with FDA and cGMP standards, while Hikal was hit with a warning letter due to repeated metal contamination.
Sept. 12, 2025
Editors' (re)View
Editor’s (re)View: It matters if Big Pharma is fudging its US investment numbers
Sept. 5, 2025
Editors' (re)View
Editor’s (re)View: Watch out China, India’s CRDMOs have you in their crosshairs
Aug. 29, 2025
Editors' (re)View
Editor’s (re)View: What J&J’s $2B US manufacturing investment says about Trump’s tariff-driven onshoring strategy
Aug. 22, 2025
Editors' (re)View
Editor’s (re)View: Trump seeks supply chain resilience for certain drug APIs. What about auxiliary chemicals?
Aug. 15, 2025
Editors' (re)View
Editor’s (re)View: Trump, The Art of the Deal, and pharmaceutical tariffs
Aug. 8, 2025
Editors' (re)View
Editor’s (re)View: US-EU trade deal puts pharma industry at substantial fiscal risk: GlobalData
Aug. 1, 2025
Editors' (re)View
Editor’s (re)View: AstraZeneca, Biogen, Thermo Fisher latest to jump on US investment bandwagon
July 25, 2025
Editors' (re)View
Editor’s (re)View: PCI Pharma’s $10B valuation and the rest of the CDMO sector
July 18, 2025
Looking for Something?
Load More Content
Back To Top